UBC’s Post

AI, ML, NLP, LLM, automation; all the talk about advancing PV solutions moving forward. Take a read below as an example of how UBC is forging ahead with integration of these advancements in to our PV and Safety Global Solutions. Ping me to discuss in more detail.

AI is Changing the Game in Drug Safety! Pharmacovigilance, or drug safety monitoring, is evolving fast, and AI is leading the way! With the growing complexity of data, traditional methods are being pushed to their limits. That’s why Cloudbyz is using AI to automate processes, detect adverse events quicker, and manage risks proactively. From smarter adverse event reporting to early detection of safety signals, AI is making drug safety faster and more efficient than ever before. 🚀 Want to know how? Check out how Cloudbyz is shaping the future of pharmacovigilance. 🔗 Read more: https://hubs.li/Q02RrKs30 #AI #Pharmacovigilance #DrugSafety #PatientSafety #Innovation #Cloudbyz #LifeSciences

AI is Changing the Game in Drug Safety! Pharmacovigilance, or drug safety monitoring, is evolving fast, and AI is leading the way! With the growing complexity of data, traditional methods are being pushed to their limits. That’s why Cloudbyz is using AI to automate processes, detect adverse events quicker, and manage risks proactively. From smarter adverse event reporting to early detection of safety signals, AI is making drug safety faster and more efficient than ever before. 🚀 Want to know how? Check out how Cloudbyz is shaping the future of pharmacovigilance. 🔗 Read more: https://hubs.li/Q02RrLS50 #AI #Pharmacovigilance #DrugSafety #PatientSafety #Innovation #Cloudbyz #LifeSciences

The EU AI Act 2023 is paving the way for AI regulation and will impact pharmacovigilance (PV). From enhanced safety surveillance to streamlined reporting, AI is the future of PV, but adhering to this key AI legislation is critical to success. Learn more. https://hubs.li/Q02m6H3b0 #PatientsFirst #SafetyandRiskManagement #Pharmacovigilance #PV #PatientSafety #AI

Embracing AI in Pharmacovigilance: A Historical Perspective Towards Safer Therapeutics The integration of artificial intelligence (AI) in pharmacovigilance (PV) is a progressive journey that began decades ago. The inception of PV dates back to the tragic thalidomide disaster in the 1960s, prompting the World Health Organization to establish a global drug monitoring program. As we ventured into the digital age, the early idea to improve the effectiveness of writing could be to use more concrete examples to illustrate the role of AI in pharmacovigilance. This would help readers better understand the practical applications of AI in drug safety and make the content more engaging. Another idea could be to provide more context on the challenges faced by pharmacovigilance professionals and how AI can help address these challenges. This would help readers appreciate the significance of AI in drug safety and better understand why it is an essential tool for this field. 1990s marked the first use of AI methods for human safety data, with a steady increase in application since the 2000s². These AI algorithms, initially rudimentary, have evolved to process and analyze pharmacovigilance-related data with increasing sophistication, addressing challenges such as data quality and quantity, human resource limitations, and technological advancements³. AI in PV stands as a testament to the relentless pursuit of drug safety. It enhances our ability to predict and prevent adverse drug reactions by sifting through vast databases of patient records, clinical trials, and real-world evidence with unprecedented speed and accuracy. This not only accelerates the detection of potential drug risks but also allows for more personalized risk assessments, tailoring drug safety to individual patient profiles. Moreover, AI’s predictive capabilities are paving the way for proactive pharmacovigilance. Instead of reacting to adverse events, we can now anticipate them, mitigating risks before they manifest. This proactive stance is crucial in ensuring patient safety and maintaining public trust in healthcare systems. As we continue to harness the power of AI, we’re not just enhancing pharmacovigilance; we’re transforming it into a more robust, efficient, and patient-centric pillar of healthcare. #Pharmacovigilance #ArtificialIntelligence #DrugSafety #HealthcareInnovation Reference https://lnkd.in/gFqqxAxh https://lnkd.in/gr5_teC9 https://lnkd.in/gXAzWdKg

AI is Changing the Game in Drug Safety! Pharmacovigilance, or drug safety monitoring, is evolving fast, and AI is leading the way! With the growing complexity of data, traditional methods are being pushed to their limits. That’s why Cloudbyz is using AI to automate processes, detect adverse events quicker, and manage risks proactively. From smarter adverse event reporting to early detection of safety signals, AI is making drug safety faster and more efficient than ever before. 🚀 Want to know how? Check out how Cloudbyz is shaping the future of pharmacovigilance. 🔗 Read more: https://hubs.li/Q02RrKPG0 #AI #Pharmacovigilance #DrugSafety #PatientSafety #Innovation #Cloudbyz #LifeSciences

AI is Changing the Game in Drug Safety! Pharmacovigilance, or drug safety monitoring, is evolving fast, and AI is leading the way! With the growing complexity of data, traditional methods are being pushed to their limits. That’s why Cloudbyz is using AI to automate processes, detect adverse events quicker, and manage risks proactively. From smarter adverse event reporting to early detection of safety signals, AI is making drug safety faster and more efficient than ever before. 🚀 Want to know how? Check out how Cloudbyz is shaping the future of pharmacovigilance. 🔗 Read more: https://hubs.li/Q02RrM5S0 #AI #Pharmacovigilance #DrugSafety #PatientSafety #Innovation #Cloudbyz #LifeSciences

AI is Changing the Game in Drug Safety! Pharmacovigilance, or drug safety monitoring, is evolving fast, and AI is leading the way! With the growing complexity of data, traditional methods are being pushed to their limits. That’s why Cloudbyz is using AI to automate processes, detect adverse events quicker, and manage risks proactively. From smarter adverse event reporting to early detection of safety signals, AI is making drug safety faster and more efficient than ever before. 🚀 Want to know how? Check out how Cloudbyz is shaping the future of pharmacovigilance. 🔗 Read more: https://hubs.li/Q02RrLVS0 #AI #Pharmacovigilance #DrugSafety #PatientSafety #Innovation #Cloudbyz #LifeSciences

Social media listening for #pharmacovigilance #drugsafety is a field that we've been pioneering in CREATION.co for more than a decade, and is increasingly being adopted for early signal detection. Here's a helpful summary from John Praveen of the state of the art in #socialmedia #pharmacovigilance using #GenAI.

Harness the Power of AI in Pharmacovigilance Leaders in clinical and regulatory fields are turning to AI to stay ahead in drug safety. From streamlining literature monitoring to improving compliance, AI-driven pharmacovigilance solutions are transforming the way we manage safety data. Discover how this technology can reduce manual work, mitigate risks, and drive smarter decision-making in your organization. Curious how AI can make a difference? 🔗 Read the full blog: https://hubs.li/Q02Tccbg0 #Pharmacovigilance #DrugSafety #AIinPharma #ClinicalOperations #Compliance #RegulatoryAffairs #Cloudbyz